ロード中...
Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?
The hallmark of CML (chronic myeloid leukaemia) is the BCR (breakpoint cluster region)–ABL fusion gene. CML evolves through three phases, based on both clinical and pathological features: a chronic phase, an accelerated phase and blast crisis. TKI (tyrosine kinase inhibitors) are the treatment modal...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Portland Press Ltd.
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3839595/ https://ncbi.nlm.nih.gov/pubmed/24070327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20130067 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|